CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Cordis AAA stent graft system "INCRAFT TM"device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01106391
NCT01106391N/ACompleted

A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With Abdominal Aortic Aneurysms

Cordis US Corp.·interventional·Posted Apr 19, 2010·Updated Jan 12, 2023

In Brief

A clinical study evaluating Cordis AAA stent graft system "INCRAFT TM" for Abdominal Aortic Aneurysms. Completed, enrolled 60 participants across 1 site.

Detailed Summary

This study is a multi-center prospective, open label, non-randomized investigation of INCRAFT™ in subjects with abdominal aortic aneurysms. The study will enroll up to 60 subjects in up to 7 sites in Germany and Italy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 19, 2010
Enrollment StartMar 1, 2010
Primary CompletionAug 1, 2011
Study CompletionOct 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 16.2 years ago

Interventions

Cordis AAA stent graft system "INCRAFT TM"device